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Abstract.  12 distinct neural cell adhesion molecule 
(N-CAM) epitopes, each recognized by a different 
monoclonal antibody (mAb), have been characterized 
in terms of the major structural and functional features 
of the molecule. Seven antibodies, each recognizing 
the amino-terminal region of the molecule, altered the 
rate of N-CAM-mediated adhesion. Four of these 
were inhibitors, two of which also recognized a 
heparin-binding N-CAM fragment. The other three 
antibodies specifically enhanced the rate of 
N-CAM-mediated adhesion. Three epitopes, one 
polypeptide- and two carbohydrate-dependent, were as- 
sociated with the sialic acid-rich central portion of the 
molecule. The remaining two antibodies were found to 
react with intracellular determinants, and are specific 
for the largest of the three major N-CAM polypeptide 
forms. Studies on the ability of one antibody to hinder 
recognition of native N:CAM by another antibody sug- 
gested that the epitopes associated with N-CAM bind- 
ing functions are in close proximity compared with the 
other determinants. The classification of these mAb 
epitopes has allowed the topographical placement of 
key N-CAM features, as described in the following 
paper,  and provides valuable probes for analysis of 
both the structure and function of N-CAM. 
N 
EORAL cell adhesion molecule (N-CAM) ~  is a mem- 
brane glycoprotein that serves as a homophilic li- 
gand in the formation  of adhesions between ceils 
(29).  This molecule is expressed by several types of cells 
during  embryogenesis,  including nerve,  muscle,  and glial 
cells of the developing nervous system (see reference 26). 
N-CAM-mediated  adhesion is involved in a variety of de- 
velopmental events, including axon guidance (32, 34), segre- 
gation of cells into discrete regions and layers (1, 30),  and 
the formation and innervation of muscles (28, 35). The abil- 
ity of the molecule to contribute to the specificity of these 
intricate structures and processes is reflected not only in an 
elaborate spatial and temporal regulation of its expression, 
but  also  in variations  in its polypeptide  and carbohydrate 
structure  (26, 27). 
Significant progress has been made in describing some of 
the major chemical  properties  of N-CAM,  as well as the 
genetic basis for generating its different polypeptide forms 
(27). In integrating this information into the biology of cell- 
cell adhesion,  it is useful to create models that relate these 
properties  to  each  other  and  to  the  overall  function  of 
N-CAM, and to obtain specific probes for individual molec- 
ular structures and functions. For a number of  large polypep- 
tides, an effective approach to both of these goals has been 
to generate a library  of monoclonal antibodies (mAbs) se- 
lected and characterized with respect to their ability to recog- 
nize or perturb specific domains and activities (9,  11, 13, 19, 
1. Abbreviations  used in this paper: Endo-E-N, endoneuraminidase F and 
N; N-CAM, neural cell adhesion molecule. 
22).  In this  study we have established  such a library  for 
N-CAM. In the accompanying report (10) the associated epi- 
topes are mapped into a molecular model of this transmem- 
brane glycoprotein. 
Materials and Methods 
Electrophoresis and Immunoblotting 
Samples were boiled for 3 rain in SDS sample buffer and separated by elec- 
trephoresis in 7, 7.5, 10, or 15% polyacrylamide gels containing SDS (20). 
Gels were silver stained according to the method of Oakley et al. (24)  or 
transferred to nitrocellulose for immunoblotting (36). For the blots, ascites 
fluid or monoclonal IgG were diluted in Blotto (18) and incubated with the 
sample for at least 3 h at room temperature. UnreacW.d antibody was re- 
moved by a series of four 5-rain washes in a phosphate buffer (36). Bound 
antibody  was  reacted  with  ~25I-affinity-purified  second  antibody  (New 
England Nuclear, Boston, MA or Amersham Corp., Arlington Heights, IL) 
and visualized by autoradiography on Kodak X-Omat AR x-ray film with 
an enhancing screen (33)  or with peroxidase-conjugated goat anti-mouse 
Ig and visualized by development with 4-chloro-l-napthol (16). 
Preparation of N-CAM 
For preparation of N-CAM fragments and for production of mAbs N-CAM 
was purified by immunoaftinity chromatography as previously described 
(17), using rnonoclonal PP coupled to Sepharose 4B (Pharmacia Fine Chem- 
icals,  Piscataway,  NJ).  For  purposes of immunoblotting with  different 
mAbs,  the  three  major  molecular  mass  forms  of N-CAM  present  in 
sonication-disrupted 2.5-wk-old chicken optic nerve, chiasm, and tract tis- 
sue (1 vol tissue/5 vol PBS) were partially desialylated by treatment of the 
sonicate with endoneuraminidase N (31) (endo-N; 1 gl/3 I.tg tissue for 1 h 
at 4°C) and separated by SDS PAGE.  The endo-N digestion was stopped 
by addition of an equal volume of2x SDS PAGE sample buffer and boiling 
for 3 min. 
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mAbs 10A, llB,  9A,  12B, 79B,  5E, 30B,  and 4D were produced against 
purified  N-CAM  using  published  procedures  (25)  with  the  following 
modifications. BALB/C mice (Charles River Breeding Laboratories, Inc., 
Wilmington, MA) were immunized with 20-30 gg of N-CAM in complete 
Freund's adjuvant. The mice were boosted three to five times with 10-20 
~tg N-CAM in incomplete Freund's adjuvant at 1-mo intervals. 3-4 d before 
fusion, immune mice were given an intraperitoneal injection of 50 gg of 
N-CAM in PBS. Spleen cells were harvested, fused with a nonsecreting my- 
eloma cell line (P3X63-Ag8.653)  and hybrids selected by published proce- 
dures (25). 
Media from hybrid clone cultures were tested for anti-N-CAM antibody 
by the solid-phase ELISA (37) using undenatured, purified N-CAM and 
o-phenylenediamine  as substrate for the peroxidase. Cultures giving a posi- 
tive reaction against undenatured N-CAM were cloned by limiting dilution 
(25)  to ensure that they were monoclonal. Ascites fluid was produced for 
a number of hybridomas by injecting 5-10  ×  106 cells into pristane-primed 
BALB/C mice and collecting fluid 10-30 d later (2). 
Antibodies PP and CHO (34), 104 (gift of Drs. Sigrid Henke-Fahle and 
Friedrich Bonhoeffer, Institute for Developmental Biology,  Federal Repub- 
lic of Germany) and 105 (21; gift of Dr. David Gottlieb, Washington Univer- 
sity School of Medicine, St. Louis, MO) were obtained by similar proce- 
dures, except that neural membranes or cells were used as the immunogen. 
The ability of these reagents to recognize epitopes on N-CAM was estab- 
lished either by the immunoblot pattern obtained with SDS PAGE of neural 
tissue or by their binding to purified N-CAM in the ELISA assay, 
The immunoglobulin subclass of each mAb was determined with a kit 
from Boehringer Mannheim Biochemicals (Indianapolis, IN) according to 
manufacturers directions. The mAbs used for the following studies were 
found to be gamma-l/kappa, except CHO, which was mu/kappa (data not 
shown). 
The IgG fraction of the ascites fluids was prepared either by dialysis 
against 20 mM Tris, pH 7.2, followed by chromatography on Affi-Gel Blue 
(Bio-Rad Laboratories, Richmond, CA) or by ammonium sulfate precipita- 
tion, dialysis, and chromatography on DE-52 (Whatman, Inc., Clifton, N J). 
Affi-Gel Blue columns were eluted sequentially with the same buffer con- 
taining 100 mM NaCI. DE-52 columns were eluted with a continuous gra- 
dient of NaC1 from 0 to 50 mM in the starting buffer, 25 mM sodium phos- 
phate, pH 7.5. Purity of Ig was monitored by SDS PAGE using 15% gels 
and silver stain. Fab fragments of  each mAb were prepared from the purified 
Ig by digestion with papain (200:1 wt/wt oflg to papain) for 6-12 h at 37°C 
(23)  so that no intact heavy chain was detectable. 
Membrane Vesicle  Aggregation 
The ability of Fab fragments of the isolated mAbs to affect aggregation of 
brain membrane vesicles prepared from El4 chicken brain was analyzed by 
determining the rate of  decrease in membrane particle number using a parti- 
cle counter (ZB1; Coulter Electronics, Inc., Hialeah, FL) with a  100-~tm 
aperture tube (31). Membrane vesicles were prepared on the day of  the assay 
as previously described (17). Vesicles, 15-20 ~tl of a 10% vol/vol suspension 
in PBS, were incubated in a total volume of 50-100 gl with 25-100 I~g of 
either control nonimmune Fab or 25-100 gg immune Fab for 15 rain at 0°C. 
To initiate aggregation, sample volume was increased to 0.5 ml with 37°C 
PBS. Aggregation was carried out at 37°C at 70 rpm rotary oscillation in 
20-ml glass scintillation vials, and stopped at timed intervals by dilution of 
50 Ixl reaction mixture into 15 mi  1% glutaraldehyde in PBS. 
Immunostaining of  Intact and Permeabilized Cells 
Retinal cells were prepared from neural retina of 9-11-d chick embryos by 
trypsinization (0.25% trypsin for 15 rain in 0.02%  EDTA in calcium and 
magnesium-free medium) followed by washing with PBS containing soy- 
bean trypsin inhibitor (0.052%  inhibitor, 0.3% BSA, 0.004%  DNAse) and 
dispersal of the cells with a pipette. 
Staining was carried out both with the freshly trypsinized cells and with 
cells that had been cultured. The freshly trypsinized cells were kept at 4°C 
while being immobilized by centrifugation onto glass cover slips coaled 
with waxbean agglutinin (15) and then immediately stained with antibody. 
Thus, the cells were never allowed to replace surface components cleaved 
by the original trypsinization. The cultured cells were prepared by plating 
on acid-washed, polylysine-coated glass coverslips (5  ×  10  ~ cells/cover- 
slip) and culturing for 2 d in Dulbecco's modified Eagle's medium (Gibco, 
Grand Island, NY) with 10% FCS. 
Staining was carded out both with and without permeabilization of the 
ceils by treatment with methanol at  -20°C for 5 rain. The cells were in- 
cubated for 30 min at 4°C with the indicated mAb diluted in PBS containing 
10% normal goat serum. The cells were then washed five times with Hanks' 
balanced salt solution, incubated 30 min at room temperature in fluorescein- 
conjugated goat-anti mouse IgG (Cooper Biomedical, Inc., Malvern, PA), 
washed again, and fixed in -20°C methanol for 5 min. The coverslips were 
mounted on slides using 2 % n-propyl gallate in glycerol to reduce pho- 
tobleaehing. 
Binding of  mAbs to Membrane Vesicles 
The effect of preincubation of brain membrane vesicles with one mAb on 
the subsequent binding of a  second 125I-labeled antibody was used as a 
criterion for epitope proximity on native, membrane-associated N-CAM. 
Purified Ig or concentrated ascites fluid were iodinated by a modification 
of the Enzymo-Bead method (Bio-Rad Laboratories). 50 [tl of a 2 mg/ml 
Ig solution or 50 gl of ascites fluid was incubated with 10 gl (0.5 mCi) ~sI, 
50 I~1 rehydrated Enzymo-Beads, and 25 Ixl 1% o-glucose for 30 rain. The 
iodination was stopped by dilution with I ml PBS. Ion exchange resin (AGI- 
X8, chloride form; Bio-Rad Laboratories) was added to adsorb unreacted 
iodine. 
Binding and competition experiments were performed with freshly pre- 
pared 14-d chick embryo brain membrane vesicles (17). Vesicles (100 btl of 
a 1% wt/vol solution) were incubated in 12  x  75-ram test tubes for 15 rain 
on ice with nonradioactive antibody (50 gg in 50 ~tl PBS containing 10% 
horse serum and 3 % BSA) and an additional 15 min with iodinated antibody 
(50,000 cpm/50 ~tl). Samples were then diluted with 1 ml PBS, pelleted at 
2,800 rpm for 15 min at 4°C, and assayed for bound radioactivity. 
Preparation of the Amino-terminal  65-kD Fragment 
The 65-kD Frl fragment of N-CAM was prepared as previously described 
(17).  Briefly,  this  involves incubation  of twice  immunoaffinity-purified 
N-CAM at 37°C for 96-115 h in sodium bicarbonate buffer, pH 8.3, contain- 
ing 0.1% sodium azide, followed by gel filtration on Sephacryl S-300 in the 
same  buffer.  The  included  peak  was  pooled,  lyophilized,  rechromato- 
graphed on the same column, and then immunoaffinity-purified (17) using 
monoclonal PP coupled to Sepharose 4B. 
Preparation of  a 25-kD Heparin-binding Fragment 
A 25-29-kD subtilisin fragment of N-CAM, isolated by affinity chromatog- 
raphy  on heparin-agarose (Sigma Chemical  Co.,  St.  Louis,  MO),  was 
generously provided by  Drs.  Greg  Cole  and  Lnis  Glaser,  Washington 
University, St. Louis, MO. This fragment can be used as a substrate for at- 
tachment of cells to plastic surfaces and also perturbs N-CAM-mediated 
cell-cell adhesion (3, 4). 
Preparation and Characterization of a Polysialic 
Acid-containing Fragment 
A cyanogen bromide (CNBr) fragment of N-CAM that carries the majority 
of the molecule's sialic acid was prepared by published procedures (5). 
Affinity-purified N-CAM  was reduced and alkylated,  then subjected to 
CNBr cleavage (8 mg N-CAM, 450 mg CNBr in 9 ml 70%  formic acid) 
for 45 min at room temperature. The sample was diluted with 100 mi H20, 
lyophilized to remove unreacted CNBr, and the digest fractionated by gel 
filtration on a Sephacryl S-300 column equilibrated with 0.1 M ammonium 
bicarbonate. Column fractions were analyzed for sialic acid by the method 
of Warren (38) as modified by Hahn et al. (14). Fractions containing the in- 
cluded peak of sialic acid were pooled, concentrated by lyophilization, and 
treated with Vibrio cholera neuraminidase (Calbiochem-Behring Corp., La 
Jolla, CA), endo-F (gift of Drs. John Elder and Steve Alexander, Scripps 
Clinic and Research Foundation, San Diego, CA), or endo-N (gift of Dr. 
Eric Vimr, University of Illinois at Urbana-Champaign). The samples were 
then separated by SDS PAGE and the gels either silver stained or blotted 
and stained with mAbs. Vibrio cholera neuraminidase digestions were car- 
ried out at pH 5.8 in 0.1 M sodium acetate, 0.2 mM EDTA, and 2 mM cal- 
cium chloride for 16 h at 37°C (1  U  neuraminidase/300 Ixg sialic acid). 
Endo-N digests were carried out for 60 min at 4°C in PBS containing 1.5 
U enzyme/3 ~g sialic acid. Endo-F digestions (6 U enzyme/3 I.tg sialic acid) 
were performed on material that had been boiled 2 min after a 1:1 dilution 
in pH 6.1 buffer containing 1(30 mM sodium phosphate, 50 mM EDTA, 1% 
NP-40,  1% mercaptoethanol, and 0.1%  SDS (7). 
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From a  collection of over 100 hybridoma clones whose su- 
pernatants reacted with undenatured N-CAM,  12 antibodies 
were selected for their ability to recognize, in SDS PAGE im- 
munoblots, epitopes associated with both intact N-CAM and 
proteolytic fragments of the molecule.  These reagents have 
been assigned the trivial names 79B, 5E,  12B, PP, 9A,  liB, 
10A,  104,  105, CHO, 30B, and 4D. The selected hybridomas 
were subcloned by limiting dilution, and again shown to pro- 
duce antibodies reactive with purified N-CAM. These clones 
were  injected  into  mice to produce  ascites  fluid,  each  of 
which only contained N-CAM-reactive antibodies of a  sin- 
gle subtype.  Together, these procedures and analyses were 
used as criteria that the antibodies were in fact monoclonal 
with respect to N-CAM antigenic determinants. The antibod- 
ies were then tested for several properties:  (a) the ability to 
alter  the  rate  of brain  membrane  vesicle  aggregation,  (b) 
reaction with extra- and intracellular epitopes, (c) inhibition 
among  the  antibodies  for binding  to  native  N-CAM,  (d) 
specificity for carbohydrate versus protein determinants, and 
(e)  recognition  of fragments  representing  several  defined 
N-CAM structural and functional domains. 
Effects of the mAbs on Membrane- 
Membrane Adhesion 
To avoid distortion of this assay by IgG-mediated agglutina- 
tion  of the  membrane  vesicles,  each  antibody  tested  was 
cleaved into the monovalent Fab form and analyzed by elec- 
trophoresis.  If heavy chain was still detectable,  the cleavage 
was repeated until complete (Fig.  1). The effect of these Fab 
fragments  on the rate of brain membrane vesicle aggrega- 
tion, relative to the rate observed in the presence of nonim- 
mune Fab, is shown in Fig. 2. Based on these results the anti- 
bodies  could be  divided  into three  groups:  those  with  no 
effect (4D,  30B,  and  105),  those that decreased the rate of 
aggregation (79B,  5E,  12B,  and PP;  t  test P  <  0.005),  and 
those that enhanced aggregation (gA,  llB; t test P  <  0.005). 
Figure 1. Representative  SDS PAGE analyses of Fab fragments used 
in the adhesion assay shown in Fig.  2. The silver-stained  compo- 
nents of representative  monoclonal IgGs after papain digestion  are 
shown:  lane a,  5E;  lane b,  llB  after  one digestion;  lane  c,  liB 
6 h after two digestions;  lane d, 105; lane e, 30B after one digestion; 
and lane f, 30B after two digestions.  When heavy chain was still 
detected  after one digestion,  as with  llB (lane b) and 30B (lane e), 
the cleavage was repeated (lanes c and f). Comparable results were 
obtained  with the other antibodies  used in the adhesion assay. 
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Figure 2. The effect of  anti-N-CAM Fabs on the rate of  brain mem- 
brae vesicle aggregation.  Fab fragments of tmlyclonal and mono- 
clonal antibodies  were added to the vesicles  and the initial rate of 
aggregation at 37°C was monitored with a panicle counter.  100% 
aggregation was taken as the percent decrease in particle number 
(typically 40%) after 20 rain in the presence of the control nonim- 
mune (N1) Fab. Each Fab was tested 4-12 times and the standard 
error of the mean of these determinations  is shown.  The mono- 
clonal Fabs could be placed into three categories: those that in- 
hibited (12B, PP, 79B, and 5E), those that enhanced (llB, 9A, and 
10A), and those that had no effect (105, 30B, and 4D) on aggrega- 
tion.  Combinations  of the  inhibitory  monoclonal Fabs  blocked 
aggregation  up to 80%  (12B plus 5E), but never as well as rabbit 
imlyclonal  anti-N-CAM Fab (PAb). 
Antibody 10A caused a weaker but significant degree of en- 
hancement.  The degree of inhibition was always lower than 
that obtained with polyclonal anti-N-CAM Fab (Fig. 2), but 
the  rate of aggregation could be decreased by as  much as 
70-80%  by combining different inhibitory monoclonal rea- 
gents, for example 12B and 5E. The two antibodies directed 
against carbohydrate determinants (see below) did not affect 
adhesion (data not shown).  However, these antibodies react 
with  several  different  glycoproteins  (unpublished  observa- 
tions) and therefore were not routinely included in analyses 
involving unfractionated  membrane proteins. 
Table L mAb Staining of  Intact and Methanol- 
permeabilized Retinal Cells 
Cultured cells*  Trypsinized cells* 
Antibody  -  MeOH  + MeOH  -  MeOH  + MeOH 
Nonimmune  .... 
10A  + +  +  -  - 
llB  ++  +  -  - 
9A  +++  ++  -  - 
12B  +++  +++  -  - 
PP  +++  +++  -  _ 
79B  +++  +++  -  - 
5E  +++  +++  -  - 
105  ++  +++  -  - 
30B  5:  +++  -  +++ 
4D  -  +  -  +++ 
Staining appeared as a ring of patches around the cell perimeter and along neu- 
ronal processes (see Fig. 3). The relative intensity of the staining is indicated 
using an excess of antibody; +  refers to staining that was only slightly above 
background and did not have a  patchy distribution. 
* Cultured cells have been allowed to re-express surface proteins that were 
cleaved during dissociation of the retinal tissue using trypsin. Trypsinized cells 
were stained immediately after the tissue dissociation. 
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were cultured for 2 d and stained by indirect immunofluorescence methods, either live or after treatment with -20°C methanol for 5 min. 
The mAbs fell into two groups,  one group represented here by PP, which stained strongly both without (A) and with permeabilization 
(B), and the other group, represented by 4D, which stained permeabilized (D) but not intact (C) cells. The results obtained for all antibodies 
tested are summarized  in Table I. Bar, (A) 10 lam. 
Reaction with Extracellular and Cytoplasmic Domains 
The antibodies were classified based on their ability to react 
with extraceUular versus membrane-protected or intracellu- 
lar determinants. Cultured, viable retinal cells showed posi- 
tive  immunofluorescence  staining,  appearing  as  a  ring  of 
patches around the cell perimeter, with all polypeptide-spe- 
cific antibodies except 30B and 4D. This extracellular stain- 
ing was not observed if freshly trypsinized cells were used. 
Antibodies 30B and 4D did not stain cells with intact mem- 
branes,  but  did  stain  both  cultured  and  trypsinized  cells 
whose surface membrane had been permeabilized with meth- 
anol. Thus 30B and 4D appear to recognize intracellular de- 
terminants. Nonimmune Fab did not stain cells under any of 
the conditions used.  These data are summarized in Table I 
and representative staining is shown in Fig.  3. 
In  terference among An tibodies in Binding 
to Brain Membrane Vesicles 
Fig. 4 summarizes the competition between pairs of labeled 
and unlabeled mAb for binding to native, membrane-bound 
N-CAM. Under the conditions used, each antibody was able 
to block its own binding by >90 % except 105, which com- 
pleted 75 % of its own binding.  A  different pattern of inhi- 
bition was observed for each antibody.  Differences in the 
affinity of two antibodies for the same epitope do not appear 
to be sufficient to explain the patterns. The results therefore 
suggest each antibody is directed against a distinct epitope, 
but do not rule out the possibility that two epitopes share a 
common structural feature. Only antibody 105 did not affect 
the binding of other antibodies. In some cases the inhibition 
between antibodies was reciprocal (9A and  liB,  for exam- 
pie); in others (5E and 79B)  it was not,  suggesting that the 
relative affinity of one (5E) is higher than the other (79B). 
Interference was not restricted to antibodies having similar 
effects on aggregation, as evidenced by the competition be- 
tween PP (inhibitor of aggregation) and 9A (enhancer). 
Recognition of  Carbohydrate versus Protein- 
dependent Determinants 
Up to one-third of the weight of N-CAM is carbohydrate, in- 
cluding long chains of polysiaiic acid and other more typical 
N-linked oligosaccarides (6, 8, 17). The contribution of these 
carbohydrate moieties to epitopes recognized by the mAbs 
was assessed by immunostaining dot blots (data not shown) 
of  native  N-CAM,  neuraminidase-treated  N-CAM,  and 
N-CAM digested with endo-F (to remove all N-linked carbo- 
hydrate). All of the mAbs stained N-CAM after removal of 
sialic acid. Although both 104 and CHO failed to recognize 
N-CAM  treated with endo-F,  the  remaining  10 antibodies 
continued to react with the residue polypeptide. Thus, two 
of the monoclonal reagents require the presence of an N- 
linked, mannose-rich core structure and the other 10 appear 
to be directed primarily against polypeptide determinants. 
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Figure 4.  Interference between mAbs in their  binding  to native 
N-CAM on brain membrane vesicles. The vesicles were incubated 
with one unlabeled mAb and then tested for their ability to bind a 
second ]25I-labeled antibody. The values shown represent the per- 
cent radiolabel bound relative to controls (ctrl) in which the vesicles 
were not treated with an unlabeled antibody. Each antibody blocked 
its own binding, and in some cases the binding of other antibodies. 
The  standard  deviations  (n  ---  6)  in  the  different  combinations 
ranged from 4-7 %. 
Reactivity of  Antibodies with the 65-kD 
Amino-terminal Fragment 
Under  appropriate  conditions,  N-CAM  appears to degrade 
spontaneously,  yielding a  relatively  stable 65-kD  fragment 
that  has  been  shown  to  contain  the  amino  terminus,  cell- 
binding activity, and only a  small amount of the total sialic 
acid (6). Shown in Fig. 5 is an immunoblot of purified 65-kD 
fragment that had been run on 15 % gels and stained with the 
indicated antibodies.  All antibodies except 4D, 30B, and 105 
reacted strongly with this fragment, suggesting that most of 
the epitopes recognized in our studies are associated with the 
cell binding  domain of the molecule. 
Figure 6. Epitopes associated with the 25-kD heparin-binding frag- 
ment. Immunoblot analysis of this fragment after SDS PAGE indi- 
cated the presence of  epitopes. Antibodies in lane a, BIA3 (the rnAb 
described by Cole and Glaser in ref. 3); lane b, 5E; and lane c, 79B. 
Antibodies PP (lane d),  12B (lane e), 9A (lane  f), lib (lane g), 10A 
(lane h), CHO (lane i),  105 (lane j),  30]3 (lane k), and 4D (lane 
l) did not recognize this fragment. 
Reactivity of  Antibodies with the 25-kD 
Heparin-binding Fragment 
Cole and Glasser have recently reported that a  170-kD gly- 
coprotein  isolated  from adherons  and  containing  a  heparin 
binding  site is,  in fact, N-CAM (3, 4).  They have proposed 
that, on cells, this binding activity is directed at heparan sul- 
fate that is itself associated with the membrane, and that the 
interaction of N-CAM with the glycosaminoglycan enhances 
N-CAM-mediated  homophilic  adhesion.  Furthermore,  the 
heparin-binding  activity  has  been  associated  with  25-kD 
subtilisin  fragment of the molecule that is uniquely  recog- 
nized by a mAb B1A3.  The ability of our mAbs to recognize 
the heparin-binding  fragment after SDS PAGE is illustrated 
in  Fig.  6.  Antibodies  79B  and  5E  were  strongly  reactive, 
whereas the others produced  no staining  of material of the 
appropriate  electrophoretic  mobility. 
Figure 5.  Identification  of epitopes  associated  with  the  amino- 
terminal 65-kD fragment of N-CAM (Frl).  Partially purified Frl- 
containing digests (see Materials and Methods) were further frac- 
tionated by SDS PAGE and analyzed by immunoblotting with each 
mAb. Antibodies in lane a, 5E;  lane b, 79B;  lane c, PP; lane d, 
12B; lane e,  9A;  lane f,  liB;  lane g,  10A; and lane h,  CHO,  all 
stained Frl,  whereas lane i,  105; lane j, 30B;  and lane k, 4D, did 
not.  Antibody  104 gave the same staining pattern as CHO. 
Figure 7. Epitopes associated with the polysialic acid-containing 
CNBr fragment of N-CAM. In immunoblots, only antibodies CHO 
(A) and  105 (B) were found to recognize this fragment. The anti- 
body-stained material appeared in  SDS  PAGE as a  diffuse band 
(lane 1 ). After removal of most polysialic acid with neuraminidase, 
both antibodies predominantly recognized a band of higher electro- 
phoretic  mobility  (lane  2).  Removal  of  all  N-linked  carbohy- 
drate with endo-F yielded a 36-kD component (lane 3) that was 
stained by 105, but not by CHO. 
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forms of N-CAM. Detergent extracts of optic nerve, chiasm, and 
tract of 2.5-wk-old chickens, which contain all three forms, were 
treated with endo-N, fractionated by SDS PAGE, and analyzed by 
immunoblotting. Most of the mAbs recognized the three forms as 
shown here for 5E (lane a), PP (lane b), 9A (lane c), CHO (lane 
d), and 105 (lane e). The 104 and CHO antibodies, whose reactivity 
is dependent on carbohydrate, recognized other glycoproteins in ad- 
dition to N-CAM, as shown in lane d for CHO. Antibodies 30B 
(lane f) and 4D (lane g) reacted only with the largest polypeptide 
form of N-CAM. 
Reactivity with a 36-kD Polysialic Acid- 
containing Glycopeptide 
A CNBr fragment of N-CAM containing most of the mole- 
cule's polysialic acid was  isolated according to the proce- 
dures of Crossin et al. (5). Shown in Fig. 7 A is the reaction 
of the carbohydrate-dependent antibody CHO with this frag- 
ment. Without glycosidase treatment, this fragment migrat- 
ed as a diffuse band with an apparent molecular mass range 
of  60-150  kD.  After  treatment  with  endo-N,  the  elec- 
trophoretic mobility of the stained material was increased, 
and  removal  of N-linked  carbohydrate by  endo-F  elimi- 
nated recognition of the fragment by antibody CHO. Of the 
other mAbs  only  105  stained  the  untreated  and  endo-N- 
treated fragment. In addition, 105 also stained a 36-kD com- 
ponent in the endo-F-treated sample (Fig. 7 B), indicating 
that this antibody recognizes a polypeptide determinant as- 
sociated with the polysialic acid-containing CNBr fragment. 
Reactivity of  Antibodies with Different Polypeptide 
Forms of  N-CAM 
SDS PAGE immunoblots of detergent extracts from postnatal 
chick optic nerve, chiasm,  and tract reveal the three nat- 
urally-occurring N-CAM polypeptides that have been pro- 
posed to differ in the length of their carboxyl-terminal do- 
mains (6, 12). With our SDS PAGE conditions, the apparent 
molecular mass of these forms is 180, 140, and 120-kD after 
removal of their polysialic acid, and 160, 130, and ll0-kD af- 
ter treatment with endo-E The ability of each mAb to recog- 
nize in SDS PAGE immunoblots the three major naturally 
occurring polypeptide forms of N-CAM is shown in Fig. 8. 
Antibodies 4D and 30B appear to react only with the 180-kD 
form, while all other antibodies recognize all three forms. 
These results suggest that the 4D and 30B epitopes are lo- 
cated  within  the  carboxyl-terminal 30  kD  of the  160-kD 
N-CAM polypeptide. 
Discussion 
This report describes the identification and characterization 
of mAbs with different specificities capable of recognizing 
a variety of functional and structural features of the N-CAM 
molecule.  The  implications  of these  studies  for  specific 
N-CAM  regions  and  functions  are  considered here.  The 
results are discussed with respect to the whole molecule in 
the accompanying paper. 
Of the  12  antibodies studied,  two were directed against 
carbohydrate-dependent epitopes and the remainder against 
the  polypeptide.  The  carbohydrate-recognizing  antibody 
CHO reacted with both the 65-kD amino-terminal fragment 
and the 36-kD sialic acid-containing fragment, suggesting, 
as supported by previous studies (5, 6) and confirmed in the 
accompanying  report  (10),  that  this  antibody  recognizes 
more than one site on the molecule. Each of the polypeptide- 
dependent epitopes did not recognize more than one of the 
major N-CAM regions (binding, polysialic acid-containing, 
and cytoplasmic), and the differences in their ability to affect 
each other's binding suggests that they are directed against 
distinct determinants. 
A notable feature of the 10 anti-polypeptide reagents was 
that although they were initially selected for the ability to de- 
tect fragments of N-CAM  in  immunoblots,  seven reacted 
with the amino-terminal portion of the molecule and had a 
direct effect on cell adhesion. All but one of the antibodies 
against polypeptide-dependent determinants were produced 
through immunization and selection with purified N-CAM; 
therefore, the apparent preference of the mAbs for the bind- 
ing region does not reflect the fact that this region exists out- 
side  the  cell.  Nevertheless,  in  spite  of the  abundance  of 
monoclonal reagents that affect N-CAM binding functions, 
the ability of polyclonal antibodies to inhibit cell-cell aggre- 
gation was substantially greater than even combinations of 
the  monoclonals.  The  reason  for  this  difference  is  not 
known, but might reflect a higher affinity of some antibodies 
in the polyclonal response, or their reaction with an as yet 
unidentified N-CAM binding site. 
The seven antibodies whose Fab fragments affected cell 
adhesion could be divided into three distinct groups: two that 
inhibited adhesion and also recognized the 25-kD heparan 
sulfate-binding  domain  (5E  and  79B),  two  that  inhibited 
adhesion but did not recognize the 25-kD fragment (PP and 
12A), and three that enhanced adhesion (llB, 9A, and 10A). 
Despite the different activities of the antibodies, the prox- 
imity of their epitopes in the native conformation of the mol- 
ecule is  suggested by the  fact that pre-exposure of mem- 
branes to 9A  interfered with the subsequent binding of at 
least one antibody in each of these groups, and strong inter- 
ference was also observed within each group. 
In  contrast,  the  two  carbohydrate-dependent antibodies 
(CHO and 104) and a third polypeptide-dependent (105) anti- 
body that recognized epitopes in the sialic acid-rich frag- 
ment did not have any effect on cell adhesion. These results 
are consistent with the previous suggestion that the major 
binding  activity of N-CAM  is  associated  with  the  65-kD 
fragment and does not require carbohydrate (6). 
In summary, the present studies both expand the repertoire 
of reagents that mark the binding, polysialic acid-bearing, 
and cytoplasmic domains of N-CAM (3, 5, 6, 12) and provide 
new immunochemical probes, most notably epitopes asso- 
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cell-cell aggregation. As described in the following paper 
(15), the value of these reagents and the ability to relate them 
to antibodies and studies from other laboratories has also 
been enhanced by the use of peptide fragment mapping tech- 
niques to place the epitopes in the overall structure of the 
molecule. 
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